Description/AbstractBackground: Over 30 million Americans suffer from diabetes, and over 80 million Americans suffer
from prediabetes and is underdiagnosed within the United States. Early identification for diabetes
conditions, such as using a risk assessment tool, can reduce the medical cost for patients and practices.
This serious, debilitating disease can lead to an increased risk of complications (including stroke, heart
disease, kidney failure, foot infection leading to amputation, and even blindness).
Purpose: The purpose of this quality improvement (QI) project was to determine if the implementation
of a diabetic screening tool known as the American Diabetes Risk Test (ADADRT), in the primary care
setting by providers can help providers and patients diagnose diabetes early, and/or prevent it, most
Methods: A quantitative design method utilizing a retrospective chart review was conducted on patients
seen at the practice for the three months before the ADADRT implementation and after to evaluate for
both the primary and secondary outcomes of the QI project.
Results: An independent sample t-test was performed to determine whether there was a significance
between the ADADRT score and if patients should have proper further testing if needed. The result of
the two-tailed independent samples t-test was significant based on an alpha value of .05, t(58) =
12.65, p < .001. Another independent sample t-test was performed analyzing if there was a significance
between the ADADRT score and actually administering the tool itself. The result of the twotailed
independent samples t-test was significant based on an alpha value of .05, t(54.48) = -4.38, p < .001
Recommendations and Conclusion: ADADRT is an effective tool for identification of prediabetes and
Type II Diabetes (T2DM) and a valuable resource for providers to incorporate evidence-based treatment
plans to prevent or alter the progression of diabetes.